Download Citation
Article Source:
A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer’s disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial
Henry DS,
Pellegrino RG
(2023)
A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer’s disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.
PLOS ONE 18(10): e0292863.
https://doi.org/10.1371/journal.pone.0292863